Skip to content

144Accepted Apr 3, 5:13 PM ET

Terns Pharmaceuticals, Inc. 144

Vivo Capital Surplus Fund VIII, L.P.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:13 PM

Apr 3, 2024

Filed

Apr 3, 2024

Documents

1

Size

5.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.